JWH-018 binds to both equally the CB1 and CB2 receptors. The effects of JWH-018 are mainly attributable to the binding and activation of CB1 receptors. In observe, the compound suppresses the discharge of neurotransmitters within the central nervous program, which describes the multitude of outcomes